搜尋結果
Eli Lilly's big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
CNBC· 29 分鐘前ET. 1. Wall Street was bouncing higher Friday after, as Jim Cramer put it, a "really bad ...
First Zantac Cancer Case to Go to Trial Ends in Win for Drugmakers
Bloomberg· 23 小時前Drugmakers GSK Plc and Boehringer Ingelheim GmbH persuaded a Chicago jury to reject a
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's ...
CNBC· 1 日前Big pharma is betting billions on an up-and-coming class of cancer treatments that some on< ...
A corner of the cancer therapy market is heating up—Here are the names investors need to know ...
CNBC· 1 日前There's been a lot of attention lately on a corner of ...
Jefferies says small caps are starting to outperform and these stocks are the best way to play ...
CNBC· 2 小時前the sun, according to Jefferies. Nvidia , Wall Street's poster child of the artificial ...
Nestle to launch Vital Pursuit frozen-food brand targeting GLP-1 users
CNBC· 3 日前Nestle is launching a new frozen-food brand, Vital Pursuit, aimed at the growing & ...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters· 21 小時前A jury in Chicago on Thursday rejected an Illinois woman’s claim that the ...
JPMorgan says there's a new GLP-1 drug player and its shares can rally 80%
CNBC· 3 日前Structure Therapeutics is an overlooked player in the GLP-1 market, and could one ...
Beijing drug manufacturer aiming to develop liver fibrosis drug
China Daily· 1 日前In addition to focusing on the development and commercialization of hydronidone for ... ...
China Market Update: Alibaba & JD Offer Convertible Bonds, “Healthy” Correction Continues, Week ...
Forbes· 11 小時前Asian equities were a sea of red overnight as investors grapple with higher for longer rates, as < ...